Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction services.

ABSTRACT:

Objectives

This study evaluates the prevalence and correlates of opioid agonist therapy (OAT) discontinuation across British Columbia (BC), using a sample of individuals who used substances and accessed harm reduction sites.

Design

This study uses data from the 2019 cross-sectional Harm Reduction Client Survey (HRCS).

Setting

The 2019 survey was administered from October to December at 22 harm reduction supply distribution sites across the 5 Regional Health Authorities of BC.

Participants

The 2019 HRCS was administered among individuals who used illicit substances in the past 6 months and were aged 19 years and above.

Primary and secondary outcome measures

The primary outcome was defined as self-reported discontinuation of OAT in the past 6 months. Measu

SUBMITTER: Ziafat K 

PROVIDER: S-EPMC11752018 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature